Similar articles for PMID: 31555945

Year	Number of Results
2002	2
2003	1
2006	1
2008	2
2009	2
2010	4
2011	13
2012	12
2013	9
2014	12
2015	21
2016	27
2017	18
2018	16
2019	34
2020	58
2021	79
2022	43
2023	22
2024	0

1

The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.

Lee JW, Oh D, Eom KY, Kim JH, Kim WC, Chung MJ, Lee JH. Lee JW, et al. Clin Exp Metastasis. 2020 Feb;37(1):125-131. doi: 10.1007/s10585-019-09992-z. Epub 2019 Sep 25. Clin Exp Metastasis. 2020. PMID: 31555945

2

A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02).

Chung MJ, Cho WK, Oh D, Eom KY, Kim JH, Kim WC, Lee JH. Chung MJ, et al. J Radiat Res. 2019 Oct 23;60(5):677-684. doi: 10.1093/jrr/rrz043. J Radiat Res. 2019. PMID: 31251343 Free PMC article.

3

FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.

Mikhaeel NG, Cunningham D, Counsell N, McMillan A, Radford JA, Ardeshna KM, Lawrie A, Smith P, Clifton-Hadley L, O'Doherty MJ, Barrington SF. Mikhaeel NG, et al. Br J Haematol. 2021 Feb;192(3):504-513. doi: 10.1111/bjh.16875. Epub 2020 Jul 4. Br J Haematol. 2021. PMID: 32621535 Free article. Clinical Trial.

4

Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen.

Michaud L, Bantilan K, Mauguen A, Moskowitz CH, Zelenetz AD, Schöder H. Michaud L, et al. J Nucl Med. 2023 Apr;64(4):536-541. doi: 10.2967/jnumed.122.264740. Epub 2022 Dec 22. J Nucl Med. 2023. PMID: 36549918 Free PMC article.

5

¹⁸F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study.

Minamimoto R, Fayad L, Vose J, Meza J, Advani R, Hankins J, Mottaghy F, Macapinlac H, Heinzel A, Juweid ME, Quon A. Minamimoto R, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2883-2893. doi: 10.1007/s00259-021-05353-9. Epub 2021 Apr 28. Eur J Nucl Med Mol Imaging. 2021. PMID: 33909086 Free PMC article.

6

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.

7

Prognostic Value of Pre-Autologous Stem Cell Transplantation PET/CT in Diffuse Large B-Cell Lymphoma: The Deauville Score Is Prognostically Superior to ΔSUVmax.

Zhang XY, Song L, Wang PJ, Wang L, Li Y, Wang YY, Shi CL. Zhang XY, et al. Acta Haematol. 2020;143(2):124-130. doi: 10.1159/000500512. Epub 2019 Aug 5. Acta Haematol. 2020. PMID: 31382264

8

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.

Binkley MS, Hiniker SM, Wu S, Natkunam Y, Mittra ES, Advani RH, Hoppe RT. Binkley MS, et al. Leuk Lymphoma. 2016;57(3):604-8. doi: 10.3109/10428194.2015.1067700. Epub 2015 Aug 28. Leuk Lymphoma. 2016. PMID: 26159046

9

Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.

Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, Bar-Shalom R. Avivi I, et al. Am J Hematol. 2013 May;88(5):400-5. doi: 10.1002/ajh.23423. Epub 2013 Mar 19. Am J Hematol. 2013. PMID: 23423884 Free article.

10

Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.

Wight J, Wai SH, Shen E, Lee ST, Berlangieri S, Fancourt T, Hawkes E, Hannah A, Leung T, Chong G. Wight J, et al. Eur J Haematol. 2021 Oct;107(4):475-483. doi: 10.1111/ejh.13684. Epub 2021 Jul 22. Eur J Haematol. 2021. PMID: 34240453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

309 results

Results by year